Ultrasound Guided Central Venous Vascular Access - Novel Needle Navigation Technology Compared With Conventional Method
NCT ID: NCT03214575
Last Updated: 2017-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2016-02-01
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: To compare the success, efficacy and safety of the procedure using the ultrasound guidance (UG) with conventional versus GPS method.
Methods: This was a prospective randomized controlled study in a single centre - intensive care unit. 100 patients were randomized into two groups (50 each each). Subjects would receive CVC insertion via internal jugular vein using ultrasound guidance out of plane approach by conventional versus GPS method. Outcomes measured were the procedure efficacy, safety, level of operators' experience and their satisfaction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Ultrasound-guided Central Venous Catherterization Via the Lower Internal Jugular Vein or the Subclavian Vein
NCT03162757
Standard Ultrasound Guidance vs. New Needle-steering Device in Subclavian Venous Catheterization
NCT06050902
The Use of Point of Care Ultra Sound for Correct Placement of Central Venous Catheter
NCT02472132
Ultrasound Guidance Versus Anatomical Landmarks for CVC Catheterisation:
NCT03207932
Femoral Central Venous Access Comparison of 2 Methods
NCT02318940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods:
This was a prospective randomized controlled study. It was conducted in a single centre - intensive care unit (ICU), University of Malaya Medical Centre, Kuala Lumpur, Malaysia from February 2016 to October 2016. The ethic committee approval was obtained from the Malaysian medical research and ethics committee, MREC at the www.nih.gov.my (NMRR-16-334-29476).
The inclusion criterion was patients in the ICU who required central venous vascular access. The exclusion criteria were refusal to participate in this study by patient or their legal representative and patient with known history of difficult central venous access at internal jugular vein (IJV). The procedure operators were doctors in anaesthesia residency program with various level of experiences classified into 3 groups: 1 to \< 2 years, 2 to \< 3years, 3 years and above. Simply speaking all the operators have had previous training in ultrasound guided vascular access procedure. This would ensure that patient's safety is not compromised.
Study would be proceeded after obtaining consent from patient or the next of kin. The emergency verbal consent would be taken if the next of kin was not immediately available with subsequent written consent to follow. The available operator would perform CVC insertion via IJV using ultrasound guidance out of plane approach either with conventional method or needle guidance technology.
Study Protocol:
After obtaining consent, a computer generated randomisation would be assigned to either using the conventional or GPS method. Identified operators using GPS method would receive a standard 5 minute briefing on the needle guidance technology and got to practice with the new technology using the vascular phantom (Blue Phantom Inc., Bothell, WA, USA). The operators were allowed to practice until they were ready to perform on real patient.
All procedure would be performed using the ultrasound machine, eZono 4000 with eZGuide (eZono, Jena, Germany) and linear array transducer L3-12NGS (3-12 MHz). This ultrasound machine2 has a built-in adaptive needle recognition software called eZGuide. The navigation technology of the ultrasound device is based on an electromagnetic field that communicates with a transducer and an electromagnetic sensor sheathed by a vascular access needle. Needle movements and related magnetic field variation allow navigation system to compute the locations of the transducer and needle in the three dimensional space. The ultrasound screen would display colour coded alignment of the needle and the position of the tip relative to the imaging plane (Figure 1). Superimposed on the image is the real-time electronic needle guidance system. The dashed line represents the predicted needle trajectory. The red box represents the depth that the needle will cross the plane of the ultrasound. The solid lines on either side of the dashed line represent the actual depth of the needle. The top left corner shows a diagram of the transducer-needle relation. This allowed the user to identify the correct needle trajectory, prior to puncturing the patient's skin and maintain the chosen route to the target anatomy. Operators assigned to use GPS method would have activated the eZGuide software while those performing conventionally would have the software technology turned off when using the ultrasound machine.
The procedure time was measured in seconds using a stopwatch. The performance time was defined as time measured from placing the needle on the skin to successful vessel puncture as indicated by blood withdrawn into the syringe.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional method
For the Conventional method of ultrasound guided central venous catheter insertion,we use the ultrasound machine, eZono 4000 and linear array transducer L3-12NGS (3-12 MHz)
Conventional method
GPS method
For the GPS method, we use the ultrasound machine, eZono 4000 with built-in adaptive needle recognition software called eZGuide (eZono, Jena, Germany) and linear array transducer L3-12NGS (3-12 MHz).
GPS Method
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional method
GPS Method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Malaya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Mohd Shahnaz, MBBS, M Anes
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohd Shahnaz Hasan, MBBS
Role: PRINCIPAL_INVESTIGATOR
University of Malaya
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMRR-16-334-29476
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.